T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.52B |
| 2 |
Boeing
BA
|
+$1.89B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 4 |
Amphenol
APH
|
+$1.1B |
| 5 |
CME Group
CME
|
+$911M |
Top Sells
| 1 |
Apple
AAPL
|
+$3.87B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.1B |
| 3 |
UnitedHealth
UNH
|
+$1.83B |
| 4 |
Uber
UBER
|
+$1.56B |
| 5 |
Adobe
ADBE
|
+$1.29B |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.7% |
| 4 | Financials | 11.14% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Metallus
MTUS
$697M
| $841K | ﹤0.01% |
59,472
+779
| +1% | +$11K |
|
2027
Lindsay Corp
LNN
$1.52B
| $840K | ﹤0.01% |
7,096
+712
| +11% | +$84.3K |
|
|
ALX
2028
Alexander's
ALX
$1.25B
| $839K | ﹤0.01% |
4,191
+562
| +15% | +$113K |
|
2029
Columbus McKinnon
CMCO
$415M
| $836K | ﹤0.01% |
22,433
+1,737
| +8% | +$64.7K |
|
2030
Sally Beauty Holdings
SBH
$1.48B
| $835K | ﹤0.01% |
79,860
+5,700
| +8% | +$59.6K |
|
|
PFC
2031
DELISTED
Premier Financial Corp. Common Stock
PFC
| $833K | ﹤0.01% |
32,550
+2,428
| +8% | +$62.1K |
|
2032
American Woodmark
AMWD
$995M
| $832K | ﹤0.01% |
10,450
-1,678
| -14% | -$134K |
|
2033
Under Armour Class C
UA
$2.04B
| $831K | ﹤0.01% |
111,392
+4,478
| +4% | +$33.4K |
|
|
EFC
2034
Ellington Financial
EFC
$1.34B
| $830K | ﹤0.01% |
68,475
+8,695
| +15% | +$105K |
|
2035
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$5.48B
| $828K | ﹤0.01% |
24,864
+5,859
| +31% | +$195K |
|
2036
Ardelyx
ARDX
$1.59B
| $826K | ﹤0.01% |
162,824
-911,664
| -85% | -$4.62M |
|
2037
US Physical Therapy
USPH
$1.22B
| $826K | ﹤0.01% |
9,304
-5,333
| -36% | -$473K |
|
2038
Adtran
ADTN
$809M
| $825K | ﹤0.01% |
98,986
+6,121
| +7% | +$51K |
|
2039
National Beverage
FIZZ
$3.67B
| $822K | ﹤0.01% |
19,242
+1,565
| +9% | +$66.9K |
|
2040
AMERISAFE
AMSF
$841M
| $821K | ﹤0.01% |
15,918
+1,210
| +8% | +$62.4K |
|
2041
Stellar Bancorp
STEL
$1.61B
| $821K | ﹤0.01% |
28,953
+3,608
| +14% | +$102K |
|
|
UMH
2042
UMH Properties
UMH
$1.29B
| $820K | ﹤0.01% |
43,422
+6,488
| +18% | +$123K |
|
2043
REV Group
REVG
$3.02B
| $819K | ﹤0.01% |
25,698
-32,060
| -56% | -$1.02M |
|
2044
Ginkgo Bioworks
DNA
$593M
| $814K | ﹤0.01% |
82,815
+3,152
| +4% | +$31K |
|
2045
Liquidity Services
LQDT
$849M
| $812K | ﹤0.01% |
25,123
+3,696
| +17% | +$119K |
|
2046
Schrodinger
SDGR
$1.37B
| $811K | ﹤0.01% |
42,009
+3,376
| +9% | +$65.2K |
|
2047
OneSpan
OSPN
$588M
| $808K | ﹤0.01% |
43,566
-6,666
| -13% | -$124K |
|
2048
Liberty Live Group Series A
LLYVA
$8.95B
| $805K | ﹤0.01% |
12,081
-6,647
| -35% | -$443K |
|
2049
REX American Resources
REX
$1.01B
| $805K | ﹤0.01% |
19,287
+226
| +1% | +$9.43K |
|
|
BRSL
2050
Brightstar Lottery PLC
BRSL
$3.12B
| $804K | ﹤0.01% |
45,480
+8,295
| +22% | +$147K |
|